• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Stroke Occurs in One in Five Infective Endocarditis Patients Meta-Analysis Finds

by
November 17, 2026
in Health
Reading Time: 6 mins read
0
Stroke Occurs in One in Five Infective Endocarditis Patients Meta-Analysis Finds

Stroke Occurs in One in Five Infective Endocarditis Patients Meta-Analysis Finds

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a comprehensive systematic review and meta-analysis encompassing more than 270,000 individuals diagnosed with infective endocarditis, researchers determined that acute stroke represents a frequent complication that substantially worsens patient survival. Across 122 observational cohort studies involving 270,211 patients, ischemic stroke developed in 21 percent of cases, with a 95 percent confidence interval of 17 percent to 24 percent. Concurrently, hemorrhagic stroke occurred in 5 percent of affected individuals, with a 95 percent confidence interval of 4 percent to 7 percent, while studies that did not differentiate between ischemic and hemorrhagic events reported an unspecified stroke frequency of 19 percent, bounded by a 95 percent confidence interval of 16 percent to 22 percent. The onset of stroke was associated with more than twofold higher mortality, displaying an odds ratio of 2.35 with a 95 percent confidence interval between 1.74 and 3.16. Mortality reached 22 percent among endocarditis patients who suffered a stroke, compared to 10 percent among those without stroke, achieving statistical significance at p < 0.001.

The clinical urgency of characterizing cerebrovascular complications in infective bacterial endocarditis arises from the high burden and evolving epidemiology of the underlying disease. Bacterial infective endocarditis is an acute, life-threatening infection with an estimated population incidence of 13.8 per 100,000 individuals, a figure that has risen steadily over the preceding three decades. Even though substantial therapeutic advances have been achieved in antimicrobial therapies, overall infection-related mortality has climbed over the same period. Neurological complications, particularly ischemic and hemorrhagic strokes, have been reported to occur in between 15 percent and 40 percent of affected patients, representing some of the most disabling complications of endocardial infection. Despite the recognized clinical impact of these neurological events, fundamental questions have persisted regarding optimal patient management. Specifically, uncertainty has surrounded the utility, safety, and feasibility of mechanical thrombectomy for endocarditis-related large vessel occlusion, as well as the controversial role of pre-existing or continuing antithrombotic therapies in individuals facing active cardiac valve infection.

To resolve these clinical and therapeutic questions, the investigative team established a literature search protocol adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards and the Meta-analysis of Observational Studies in Epidemiology guidelines. The investigators systematically screened the PubMed database from inception to October 1, 2022, searching terms for endocarditis paired with stroke, ischemia, or infarction. From an initial yield of 3,729 bibliographic records, 257 complete clinical reports were evaluated for eligibility. Literature searching and full-text eligibility screening were conducted independently by two investigators, Nils Werring and Carolin Beuker, who resolved discrepancies through joint consensus review or through consultation with a third reviewer, Jens Minnerup. For clinical datasets or patient populations that appeared in multiple publications, the authors selected only the single report providing the most comprehensive and informative dataset, ultimately yielding 122 qualifying observational cohort studies for final data extraction and quantitative meta-analysis.

The selection criteria mandated peer-reviewed clinical studies in English evaluating adult patients aged 18 years or older diagnosed with infective endocarditis and reporting early stroke outcomes. The protocol defined explicit exclusion criteria: endocarditis associated with immunocompromised conditions such as HIV infection or solid organ or hematopoietic stem cell transplantation was excluded, as were strokes occurring as complications of cardiac surgery. Post-mortem autopsy studies were excluded, alongside investigations focusing exclusively on congenital heart disease or intravenous drug use, and studies reporting fewer than three stroke cases to minimize systematic bias. All 122 included publications represented hospital-based single-center or multicenter cohort studies. In addition to the literature meta-analysis, the researchers incorporated primary clinical data from an observational cohort of 18 adult patients admitted to the Neurological Department at University Hospital of Münster between 2010 and 2022 who met modified Duke criteria for definite infective endocarditis and underwent attempted mechanical thrombectomy.

The statistical synthesis relied on modeling executed in R version 4.5. Meta-analyses of proportion data were conducted through generalized linear mixed models using the metaprop function from the meta package in R. The researchers selected a random-effects framework as the primary analytical approach to accommodate expected clinical and methodological heterogeneity across the included studies. This approach accounts for between-study variability by allowing true effect sizes to vary across study cohorts, producing wider confidence intervals that reflect real-world uncertainty rather than overprecision. Common-effect estimates were calculated as sensitivity analyses. Differences between defined subgroup estimates were evaluated using two-sided z-tests for proportions, with statistical significance established at a p-value below 0.05. To evaluate stroke rates across affected valve locations, the investigators performed mixed-effects logistic meta-regression using the rma function from the metafor package in R, treating affected valves as categorical moderators and applying Holm correction for pairwise multiple comparisons.

Anatomical stratification demonstrated that valve location significantly influences stroke risk. In valvular comparisons, stroke occurred in 17 percent of patients with native valve endocarditis and 19 percent with prosthetic valve involvement. When stratified by specific valve location, stroke occurred in 32 percent of patients with mitral valve endocarditis, 25 percent of those with aortic valve endocarditis, and 11 percent of those with tricuspid valve endocarditis, with insufficient published data available for pulmonary valve cases. In logistic meta-regression, valve location served as a statistically significant predictor of stroke incidence, yielding a p-value of 0.002. Pairwise comparisons with Holm correction revealed that mitral valve endocarditis carried higher stroke risk than tricuspid endocarditis, displaying an odds ratio of 3.47 with a 95 percent confidence interval of 1.69 to 7.13 and p = 0.002. Aortic valve endocarditis likewise conferred elevated stroke risk compared to tricuspid infection, with an odds ratio of 2.44, a 95 percent confidence interval of 1.16 to 5.00, and p = 0.03. In contrast, the comparison between mitral and aortic valve endocarditis showed no statistically significant difference, yielding an odds ratio of 1.44, a 95 percent confidence interval of 0.96 to 2.15, and p = 0.08.

Microbiological analyses showed that although stroke occurred across all pathogens, Staphylococcus species were most frequently involved. Among all endocarditis patients, stroke frequency stratified by causative organism was 33 percent for Staphylococcus species (95% CI 27–39), 25 percent for Streptococcus species (95% CI 19–32), 19 percent for Enterococcus species (95% CI 14–25), 24 percent for other pathogens (95% CI 18–31), and 26 percent for blood culture-negative endocarditis (95% CI 18–35). Looking specifically at pathogen distribution among patients who experienced stroke due to infective endocarditis, Staphylococcus species constituted 38 percent of cases (95% CI 24–53), Streptococcus species represented 29 percent (95% CI 22–37), blood culture-negative endocarditis comprised 13 percent (95% CI 7–23), other pathogens accounted for 7 percent (95% CI 4–12), and Enterococcus species represented 3 percent (95% CI 1–10). Because strokes occurred across all microbiological categories, the authors emphasized that acute ischemic stroke in the setting of positive blood cultures warrants consideration of infective endocarditis regardless of the organism identified.

The meta-analysis evaluated the controversial impact of antithrombotic therapy in infective endocarditis. Stroke occurred in 37 percent of endocarditis patients with prior anticoagulant or antiplatelet use compared to 24 percent of those without prior therapy, a difference that did not reach statistical significance (p = 0.27; OR 1.24, 95% CI 0.75–2.06). Among patients who developed stroke due to endocarditis, 32 percent had received prior antithrombotic therapy compared with 19 percent of patients without stroke (p = 0.40). Existing clinical guidelines from the United States and Europe generally discourage initiating antithrombotic medications de novo in patients lacking separate indications, though recommendations differ regarding continuing pre-existing therapy. Although antithrombotics possess biological plausibility and in-vitro antithrombotic effects, clinical studies have not demonstrated clear stroke prevention, while thrombocytopenia increases hemorrhage risks. Because pre-existing antithrombotics did not reduce stroke risk and showed a numerically higher incidence, the researchers concluded that their data support discontinuing antithrombotic therapy in infective endocarditis patients where no other clinical indication exists.

Acute recanalization was assessed by pooling data from four published studies alongside the Münster cohort, totaling 110 patients who underwent mechanical thrombectomy for endocarditis-related large vessel occlusion. Successful reperfusion, defined as modified Thrombolysis in Cerebral Infarction scores of 2b or 3, was achieved in 80 percent of patients (95% CI 72–87%). Symptomatic intracranial hemorrhage occurred in 15 percent of patients (95% CI 5–36%). Despite high recanalization rates, overall mortality remained elevated at 49 percent (95% CI 32–65%), and good functional outcome at hospital discharge, defined as modified Rankin Scale scores of 0 to 2, was achieved in only 23 percent of patients (95% CI 15–32%). While intravenous thrombolysis has documented harmful effects and is discouraged in endocarditis-related stroke, mechanical thrombectomy achieved procedural recanalization rates comparable to other stroke etiologies. However, the poor clinical outcomes reflect the underlying disease severity required to form large vegetations capable of producing large vessel occlusions.

The study authors recognized several notable strengths and methodological limitations across their synthesized findings. A primary strength was the comprehensive evaluation of stroke in infective endocarditis combining a meta-analysis of over 270,000 patients with granular recanalization data from a single-center cohort. Conversely, key limitations included the predominantly retrospective design of included studies and variability in neurological ascertainment and reporting, including frequent failure to distinguish between ischemic and hemorrhagic stroke, which contributed to heterogeneity. Furthermore, a formal risk of bias assessment was not performed across the included studies. The authors noted that strokes can also arise in right-sided infective endocarditis via paradoxical embolism through a patent foramen ovale or other right-to-left shunt, reinforcing the necessity of maintaining diagnostic vigilance beyond typical left-sided presentations. In conclusion, stroke carries a substantially increased risk of death in infective endocarditis, and the authors called for prospective studies and randomized trials to identify novel prevention strategies and optimize acute treatment pathways.

Subject of Research: Stroke incidence, risk factors, and acute treatment outcomes in infective endocarditis

Article Title: Characterization and treatment of ischemic stroke in patients with infective endocarditis: a meta‐analysis

Article References: Werring, N., Bonberg, N., Heidenreich, A., Beuker, C., Noblejas-Sanchez, G., Oswald, M., Royl, G., Wagner-Altendorf, T. A., Zeller, T., Stiermaier, T., Eitel, I., Katalinic, A., Minnerup, H., & Minnerup, J. (2026). Characterization and treatment of ischemic stroke in patients with infective endocarditis: a meta‐analysis. Neurological Research and Practice, 8(1), Article 89. https://doi.org/10.1186/s42466-026-00542-z

Image Credits: AI Generated

DOI: 10.1186/s42466-026-00542-z

Keywords: infective endocarditis, ischemic stroke, hemorrhagic stroke, mechanical thrombectomy, mitral valve endocarditis, aortic valve endocarditis, tricuspid valve endocarditis, Staphylococcus species, Streptococcus species, Enterococcus species, antithrombotic therapy, recanalization, large vessel occlusion, mortality rate, intracranial hemorrhage, Duke criteria, modified Rankin scale

News Source: Cassandra Pierce. (November 17, 2026). Stroke Occurs in One in Five Infective Endocarditis Patients Meta-Analysis Finds. Scienmag.

Tags: antithrombotic therapyaortic valve endocarditisDuke criteriaEnterococcus specieshemorrhagic strokeinfective endocarditisintracranial hemorrhageischemic strokelarge-vessel occlusionmechanical thrombectomymitral valve endocarditismodified Rankin Scalemortality raterecanalizationStaphylococcus speciesStreptococcus speciestricuspid valve endocarditis
Share12Tweet7Share2ShareShareShare1

Related Posts

Single High-Concentration Diazepam Nasal Spray Meets Extent Bioequivalence in Healthy Adults

Single High-Concentration Diazepam Nasal Spray Meets Extent Bioequivalence in Healthy Adults

November 18, 2026
First-Line High-Dose Aflibercept Improves Vision in Real-World Diabetic Macular Edema Cohort

First-Line High-Dose Aflibercept Improves Vision in Real-World Diabetic Macular Edema Cohort

November 18, 2026

Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

November 18, 2026

Motor Imagery Vividness Shows No Link to Parkinson’s Motor Symptom Severity

November 18, 2026

POPULAR NEWS

  • Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Motor Imagery Vividness Shows No Link to Parkinson’s Motor Symptom Severity

    29 shares
    Share 12 Tweet 7
  • Brain Tumour Review Identifies Ferroptosis Checkpoints and Spatial Therapeutic Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Hepatitis C Vesicles Maintain Immunosuppressive Signals Despite Antiviral Cure in Cirrhosis

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tunable NH-CR System Speeds Iterative Genome Engineering in Yarrowia lipolytica

Single High-Concentration Diazepam Nasal Spray Meets Extent Bioequivalence in Healthy Adults

First-Line High-Dose Aflibercept Improves Vision in Real-World Diabetic Macular Edema Cohort

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.